Cargando…

Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Klebsiella pneumoniae Infections: 2014–2022

PURPOSE: Through long-term and large sample size statistical analysis, we revealed the pattern of Klebsiella pneumoniae (KP) infection and drug resistance and provided epidemiological data for the treatment and prevention and control of multidrug-resistant bacterial infection in our hospital. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Na, Zhan, Minghua, Wang, Teng, Liu, Jinlu, Li, Caiqing, Li, Baoliang, Han, Xuying, Li, Huiying, Liu, Shuting, Cao, Jing, Zhong, Xinran, Lei, Chunmei, Zhang, Wei, Zhang, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994629/
https://www.ncbi.nlm.nih.gov/pubmed/36910515
http://dx.doi.org/10.2147/IDR.S401807
_version_ 1784902655227723776
author Wang, Na
Zhan, Minghua
Wang, Teng
Liu, Jinlu
Li, Caiqing
Li, Baoliang
Han, Xuying
Li, Huiying
Liu, Shuting
Cao, Jing
Zhong, Xinran
Lei, Chunmei
Zhang, Wei
Zhang, Zhihua
author_facet Wang, Na
Zhan, Minghua
Wang, Teng
Liu, Jinlu
Li, Caiqing
Li, Baoliang
Han, Xuying
Li, Huiying
Liu, Shuting
Cao, Jing
Zhong, Xinran
Lei, Chunmei
Zhang, Wei
Zhang, Zhihua
author_sort Wang, Na
collection PubMed
description PURPOSE: Through long-term and large sample size statistical analysis, we revealed the pattern of Klebsiella pneumoniae (KP) infection and drug resistance and provided epidemiological data for the treatment and prevention and control of multidrug-resistant bacterial infection in our hospital. PATIENTS AND METHODS: Strains were identified using the BD Phoenix(TM)100 system, minimal inhibitory concentration of antibiotics were determined by the broth method, and data were statistically analyzed using WHONET 5.6 and SPSS27.0. RESULTS: The isolation rate of KP from Enterobacteriaceae (26.2%, 4547/17358) in our hospital showed an increasing annual trend, ranking second only to Escherichia coli. Carbapenem-resistant KP (CRKP) accounted for the highest proportion of carbapenem-resistant Enterobacteriaceae (72.2%, 431/597), showing an upward trend. Infected patients had a male-to-female ratio of approximately 2:1 and were mainly >60 years of age (66.2%), with intensive care units being the most commonly distributed department. Sputum was the most common specimen type (74.0%). Compared with spring and summer, autumn and winter were the main epidemic seasons for KP and extended-spectrum β-lactamase KP (ESBL-KP). The resistance rate of KP to common antibiotics was low, but all showed an increasing trend each year. ESBL-KP was >90% resistant to piperacillin, amoxicillin/clavulanic acid, and cefotaxime and less resistant to other common antibiotics, but showed an increasing trend in resistance to most antibiotics. CRKP resistance to common antibiotics was high, with resistance rates >90%, excluding amikacin (64.1%), gentamicin (87.4%), cotrimoxazole (44.3%), chloramphenicol (13.6%), and tetracycline (30.5%). CONCLUSION: KP in our hospital mainly caused pulmonary infection in older men, which occurred frequently in autumn and winter, and the isolation and drug resistance rates showed an increasing trend. Age over 70 years, admission to intensive care unit, and urinary tract infection were found to be the risk factors for CRKP and ESBL-KP-resistance.
format Online
Article
Text
id pubmed-9994629
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-99946292023-03-09 Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Klebsiella pneumoniae Infections: 2014–2022 Wang, Na Zhan, Minghua Wang, Teng Liu, Jinlu Li, Caiqing Li, Baoliang Han, Xuying Li, Huiying Liu, Shuting Cao, Jing Zhong, Xinran Lei, Chunmei Zhang, Wei Zhang, Zhihua Infect Drug Resist Original Research PURPOSE: Through long-term and large sample size statistical analysis, we revealed the pattern of Klebsiella pneumoniae (KP) infection and drug resistance and provided epidemiological data for the treatment and prevention and control of multidrug-resistant bacterial infection in our hospital. PATIENTS AND METHODS: Strains were identified using the BD Phoenix(TM)100 system, minimal inhibitory concentration of antibiotics were determined by the broth method, and data were statistically analyzed using WHONET 5.6 and SPSS27.0. RESULTS: The isolation rate of KP from Enterobacteriaceae (26.2%, 4547/17358) in our hospital showed an increasing annual trend, ranking second only to Escherichia coli. Carbapenem-resistant KP (CRKP) accounted for the highest proportion of carbapenem-resistant Enterobacteriaceae (72.2%, 431/597), showing an upward trend. Infected patients had a male-to-female ratio of approximately 2:1 and were mainly >60 years of age (66.2%), with intensive care units being the most commonly distributed department. Sputum was the most common specimen type (74.0%). Compared with spring and summer, autumn and winter were the main epidemic seasons for KP and extended-spectrum β-lactamase KP (ESBL-KP). The resistance rate of KP to common antibiotics was low, but all showed an increasing trend each year. ESBL-KP was >90% resistant to piperacillin, amoxicillin/clavulanic acid, and cefotaxime and less resistant to other common antibiotics, but showed an increasing trend in resistance to most antibiotics. CRKP resistance to common antibiotics was high, with resistance rates >90%, excluding amikacin (64.1%), gentamicin (87.4%), cotrimoxazole (44.3%), chloramphenicol (13.6%), and tetracycline (30.5%). CONCLUSION: KP in our hospital mainly caused pulmonary infection in older men, which occurred frequently in autumn and winter, and the isolation and drug resistance rates showed an increasing trend. Age over 70 years, admission to intensive care unit, and urinary tract infection were found to be the risk factors for CRKP and ESBL-KP-resistance. Dove 2023-03-04 /pmc/articles/PMC9994629/ /pubmed/36910515 http://dx.doi.org/10.2147/IDR.S401807 Text en © 2023 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Na
Zhan, Minghua
Wang, Teng
Liu, Jinlu
Li, Caiqing
Li, Baoliang
Han, Xuying
Li, Huiying
Liu, Shuting
Cao, Jing
Zhong, Xinran
Lei, Chunmei
Zhang, Wei
Zhang, Zhihua
Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Klebsiella pneumoniae Infections: 2014–2022
title Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Klebsiella pneumoniae Infections: 2014–2022
title_full Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Klebsiella pneumoniae Infections: 2014–2022
title_fullStr Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Klebsiella pneumoniae Infections: 2014–2022
title_full_unstemmed Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Klebsiella pneumoniae Infections: 2014–2022
title_short Long Term Characteristics of Clinical Distribution and Resistance Trends of Carbapenem-Resistant and Extended-Spectrum β-Lactamase Klebsiella pneumoniae Infections: 2014–2022
title_sort long term characteristics of clinical distribution and resistance trends of carbapenem-resistant and extended-spectrum β-lactamase klebsiella pneumoniae infections: 2014–2022
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994629/
https://www.ncbi.nlm.nih.gov/pubmed/36910515
http://dx.doi.org/10.2147/IDR.S401807
work_keys_str_mv AT wangna longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT zhanminghua longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT wangteng longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT liujinlu longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT licaiqing longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT libaoliang longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT hanxuying longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT lihuiying longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT liushuting longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT caojing longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT zhongxinran longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT leichunmei longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT zhangwei longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022
AT zhangzhihua longtermcharacteristicsofclinicaldistributionandresistancetrendsofcarbapenemresistantandextendedspectrumblactamaseklebsiellapneumoniaeinfections20142022